Notice of Effectiveness
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date: March 22, 2022
Accession Number: 0001437749-22-006754
Submission Type: POS AM
CIK: 0001742927
Company Name: REVIVA PHARMACEUTICALS HOLDINGS, INC.
File Number: 333-251802